SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $98.4M invested in SPDR S&P Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 8 closing their positions.
Holders
71
Holders Change
–
Holders Change %
0%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
18
Reduced
24
Closed
8
Calls
$834K
Puts
$1.35M
Net Calls
-$519K
Net Calls Change
+$150K
Top Buyers
1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$6.63M |
2 |
2
Citigroup
New York
|
$2.22M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$1.07M |
4 |
GS
4
GTS Securities
New York
|
$1.12M |
5 |
5
Goldman Sachs
New York
|
$2.42M |